PolarityTE (Nasdaq: PTE) plans to announce its third quarter 2020 financial results on November 9, 2020, at 7:00 a.m. ET. The announcement will be followed by a conference call at 8:00 a.m. ET, which will include a Q&A session. Interested parties can join the call by phone or through a webcast. The company focuses on developing regenerative tissue products from the patient's own tissue to promote effective healing. For future updates and earnings details, visit their website.
PolarityTE, Inc. (Nasdaq: PTE) has announced the termination of its shareholder rights plan, effective September 28, 2020. This decision follows input from stockholders and aligns with the company's strategic objectives. The rights plan, commonly referred to as a 'poison pill,' is no longer in effect, and shareholders are not required to take any action regarding this change. PolarityTE aims to innovate in regenerative medicine, focusing on using patients' own tissues to create regenerative products, promoting effective healing processes.